Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000022 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 2, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
15,000
Total Value
$206,821.59
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Mar 2, 2026 | Exercise/Conversion | 5,000 | $7.80 | $39,000.00 | 242,584 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 2, 2026 | Sale | 2,325 | $33.28 | $77,386.00 | 240,259 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 2, 2026 | Sale | 2,675 | $33.81 | $90,435.60 | 237,584 | Direct | โ | View Details | |
Chief Operating Officer | Employee Warrant (right to buy) | Derivative | Mar 2, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 89,996 | Direct | โ | View Details |